GHRS correction done ?The price bounced at $17.20 and seems to build the bottom there.
Nice opportunity in my eyes, but with high risk, we don´t have much data to predict well but based on the current indicators it seems to have $20 as target.
−0.68USD
−35.59 MUSD
29.29 M
About GH Research PLC
Sector
CEO
Theis Terwey
Headquarters
Dublin
Website
Employees (FY)
49
Founded
2021
ISIN
IE000GID8VI0
FIGI
BBG011BQC379
GH Research Plc operates as a holding company, which engages in the provision of biopharmaceutical products and services. It develops therapeutic products for patients of psychiatric and neurological disorders. The firm develops novel and proprietary 5-Methoxy-N and N-Dimethyltryptamine, or 5-MeO-DMT, therapies. The company was founded by Theis Terwey, Florian Schönharting, and Magnus Halle in 2018 and is headquartered in Dublin, Ireland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of GHRS is 11.03 USD — it has decreased by 1.43% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange GH Research PLC stocks are traded under the ticker GHRS.
GH Research PLC is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
GHRS stock is 3.12% volatile and has beta coefficient of 1.29. Check out the list of the most volatile stocks — is GH Research PLC there?
One year price forecast for GH Research PLC has a max estimate of 40.00 USD and a min estimate of 18.00 USD.
GHRS earnings for the last quarter are −0.11 USD per share, whereas the estimation was −0.20 USD resulting in a 45.00% surprise. The estimated earnings for the next quarter are −0.20 USD per share. See more details about GH Research PLC earnings.
Yes, you can track GH Research PLC financials in yearly and quarterly reports right on TradingView.
GHRS stock has risen by 0.27% compared to the previous week, the month change is a 2.13% rise, over the last year GH Research PLC has showed a 33.86% increase.
GHRS net income for the last quarter is −11.27 M USD, while the quarter before that showed −5.65 M USD of net income which accounts for −99.54% change. Track more GH Research PLC financial stats to get the full picture.
Today GH Research PLC has the market capitalization of 582.19 M, it has increased by 0.18% over the last week.
No, GHRS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GHRS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GH Research PLC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 49.00 employees. See our rating of the largest employees — is GH Research PLC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GH Research PLC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GH Research PLC stock shows the buy signal. See more of GH Research PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GH Research PLC future price: according to them, GHRS price has a max estimate of 40.00 USD and a min estimate of 18.00 USD. Read a more detailed GH Research PLC forecast: see what analysts think of GH Research PLC and suggest that you do with its stocks.